We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00453583
Recruitment Status : Completed
First Posted : March 29, 2007
Last Update Posted : December 16, 2013
Sponsor:
Information provided by (Responsible Party):

March 28, 2007
March 29, 2007
December 16, 2013
March 2007
January 2008   (Final data collection date for primary outcome measure)
Parent satisfaction on a 11-point scale [ Time Frame: duration of the study ]
Not Provided
Complete list of historical versions of study NCT00453583 on ClinicalTrials.gov Archive Site
  • Physician satisfaction on an 11-point scale [ Time Frame: duration of the study ]
  • Efficacy, tolerability and global satisfaction [ Time Frame: duration of the study ]
Not Provided
Not Provided
Not Provided
 
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
Evaluation of the Treatment Satisfaction in Children Suffering From an Allergy and Who Received an Antihistamine Treatment
This is a non-interventional retrospective data collection study from children aged from 2 to 12 years old diagnosed with an allergy and who received a treatment consisting of an H1-antihistamine. The period of last taken medication will be observed to evaluate the global satisfaction of the parents and physician for this last treatment.
Not Provided
Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
Primary Care
Allergies
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
4581
January 2008
January 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Children from 2-12 included
  • History of allergy
  • Used an Antihistamine within market authorization

Exclusion Criteria:

  • Child not yet treated for the presented allergy
Sexes Eligible for Study: All
2 Years to 12 Years   (Child)
No
Contact information is only displayed when the study is recruiting subjects
United States
Bulgaria,   India,   Korea, Republic of,   Portugal,   Romania,   Russian Federation,   Spain
 
NCT00453583
A00420
Not Provided
Not Provided
Not Provided
UCB Pharma
UCB Pharma
Not Provided
Study Director: UCB Clinical Trial Call Center +1 877 822 9493 (UCB)
UCB Pharma
May 2012